Copyright Reports & Markets. All rights reserved.

Global Angiotensin Receptor Antagonists Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Angiotensin Receptor Antagonists

      • 1.1 Definition of Angiotensin Receptor Antagonists
      • 1.2 Angiotensin Receptor Antagonists Segment by Type
        • 1.2.1 Global Angiotensin Receptor Antagonists Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Valsartan
        • 1.2.3 Telmisartan
        • 1.2.4 Losartan
        • 1.2.5 Irbesartan
        • 1.2.6 Azilsartan
        • 1.2.7 Olmesartan
      • 1.3 Angiotensin Receptor Antagonists Segment by Applications
        • 1.3.1 Global Angiotensin Receptor Antagonists Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hypertension
        • 1.3.3 Cardiovascular Diseases
        • 1.3.4 Kidney Diseases
        • 1.3.5 Other
      • 1.4 Global Angiotensin Receptor Antagonists Overall Market
        • 1.4.1 Global Angiotensin Receptor Antagonists Revenue (2014-2025)
        • 1.4.2 Global Angiotensin Receptor Antagonists Production (2014-2025)
        • 1.4.3 North America Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
        • 1.4.4 Europe Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
        • 1.4.5 China Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
        • 1.4.6 Japan Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
        • 1.4.8 India Angiotensin Receptor Antagonists Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Angiotensin Receptor Antagonists
      • 2.3 Manufacturing Process Analysis of Angiotensin Receptor Antagonists
      • 2.4 Industry Chain Structure of Angiotensin Receptor Antagonists

      3 Development and Manufacturing Plants Analysis of Angiotensin Receptor Antagonists

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Angiotensin Receptor Antagonists Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Angiotensin Receptor Antagonists
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Angiotensin Receptor Antagonists Production and Capacity Analysis
      • 4.2 Angiotensin Receptor Antagonists Revenue Analysis
      • 4.3 Angiotensin Receptor Antagonists Price Analysis
      • 4.4 Market Concentration Degree

      5 Angiotensin Receptor Antagonists Regional Market Analysis

      • 5.1 Angiotensin Receptor Antagonists Production by Regions
        • 5.1.1 Global Angiotensin Receptor Antagonists Production by Regions
        • 5.1.2 Global Angiotensin Receptor Antagonists Revenue by Regions
      • 5.2 Angiotensin Receptor Antagonists Consumption by Regions
      • 5.3 North America Angiotensin Receptor Antagonists Market Analysis
        • 5.3.1 North America Angiotensin Receptor Antagonists Production
        • 5.3.2 North America Angiotensin Receptor Antagonists Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Angiotensin Receptor Antagonists Import and Export
      • 5.4 Europe Angiotensin Receptor Antagonists Market Analysis
        • 5.4.1 Europe Angiotensin Receptor Antagonists Production
        • 5.4.2 Europe Angiotensin Receptor Antagonists Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Angiotensin Receptor Antagonists Import and Export
      • 5.5 China Angiotensin Receptor Antagonists Market Analysis
        • 5.5.1 China Angiotensin Receptor Antagonists Production
        • 5.5.2 China Angiotensin Receptor Antagonists Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Angiotensin Receptor Antagonists Import and Export
      • 5.6 Japan Angiotensin Receptor Antagonists Market Analysis
        • 5.6.1 Japan Angiotensin Receptor Antagonists Production
        • 5.6.2 Japan Angiotensin Receptor Antagonists Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Angiotensin Receptor Antagonists Import and Export
      • 5.7 Southeast Asia Angiotensin Receptor Antagonists Market Analysis
        • 5.7.1 Southeast Asia Angiotensin Receptor Antagonists Production
        • 5.7.2 Southeast Asia Angiotensin Receptor Antagonists Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Angiotensin Receptor Antagonists Import and Export
      • 5.8 India Angiotensin Receptor Antagonists Market Analysis
        • 5.8.1 India Angiotensin Receptor Antagonists Production
        • 5.8.2 India Angiotensin Receptor Antagonists Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Angiotensin Receptor Antagonists Import and Export

      6 Angiotensin Receptor Antagonists Segment Market Analysis (by Type)

      • 6.1 Global Angiotensin Receptor Antagonists Production by Type
      • 6.2 Global Angiotensin Receptor Antagonists Revenue by Type
      • 6.3 Angiotensin Receptor Antagonists Price by Type

      7 Angiotensin Receptor Antagonists Segment Market Analysis (by Application)

      • 7.1 Global Angiotensin Receptor Antagonists Consumption by Application
      • 7.2 Global Angiotensin Receptor Antagonists Consumption Market Share by Application (2014-2019)

      8 Angiotensin Receptor Antagonists Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Astra Zeneca
        • 8.4.1 Astra Zeneca Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.4.2 Astra Zeneca Product Introduction, Application and Specification
        • 8.4.3 Astra Zeneca Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Jhonson and Johnson
        • 8.5.1 Jhonson and Johnson Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
        • 8.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly
        • 8.6.1 Eli Lilly Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.6.2 Eli Lilly Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb
        • 8.8.1 Bristol-Myers Squibb Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bayer
        • 8.9.1 Bayer Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.9.2 Bayer Product Introduction, Application and Specification
        • 8.9.3 Bayer Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 GSK
        • 8.10.1 GSK Angiotensin Receptor Antagonists Production Sites and Area Served
        • 8.10.2 GSK Product Introduction, Application and Specification
        • 8.10.3 GSK Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical

      9 Development Trend of Analysis of Angiotensin Receptor Antagonists Market

      • 9.1 Global Angiotensin Receptor Antagonists Market Trend Analysis
        • 9.1.1 Global Angiotensin Receptor Antagonists Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Angiotensin Receptor Antagonists Regional Market Trend
        • 9.2.1 North America Angiotensin Receptor Antagonists Forecast 2019-2025
        • 9.2.2 Europe Angiotensin Receptor Antagonists Forecast 2019-2025
        • 9.2.3 China Angiotensin Receptor Antagonists Forecast 2019-2025
        • 9.2.4 Japan Angiotensin Receptor Antagonists Forecast 2019-2025
        • 9.2.5 Southeast Asia Angiotensin Receptor Antagonists Forecast 2019-2025
        • 9.2.6 India Angiotensin Receptor Antagonists Forecast 2019-2025
      • 9.3 Angiotensin Receptor Antagonists Market Trend (Product Type)
      • 9.4 Angiotensin Receptor Antagonists Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Angiotensin Receptor Antagonists Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.

        The global Angiotensin Receptor Antagonists market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Angiotensin Receptor Antagonists volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angiotensin Receptor Antagonists market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Angiotensin Receptor Antagonists in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Angiotensin Receptor Antagonists manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Merck
        Astra Zeneca
        Jhonson and Johnson
        Eli Lilly
        Sanofi
        Bristol-Myers Squibb
        Bayer
        GSK
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Valsartan
        Telmisartan
        Losartan
        Irbesartan
        Azilsartan
        Olmesartan

        Segment by Application
        Hypertension
        Cardiovascular Diseases
        Kidney Diseases
        Other

        Buy now